ROCKET PHARMACEUTICALS, INC.

RCKTW

NASDAQBiotechnology🇺🇸North America

Drugs in Pipeline

1

Phase 3 Programs

0

Upcoming Catalysts

0

Next Catalyst

None scheduled

Drug Pipeline

Drug Name	Phase	Indication	Designations
RP-L102	Phase 2	Fanconi Anemia Complementation Group A	-

Catalyst Timeline

0 upcoming, 0 past

No catalysts found.

Regulatory Approvals

RCKTW News